Page last updated: 2024-10-22

albuterol and Cognition Disorders

albuterol has been researched along with Cognition Disorders in 1 studies

Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bozek, A1
Krajewska, J1
Jarzab, J1

Other Studies

1 other study available for albuterol and Cognition Disorders

ArticleYear
The improvement of cognitive functions in patients with bronchial asthma after therapy.
    The Journal of asthma : official journal of the Association for the Care of Asthma, 2010, Volume: 47, Issue:10

    Topics: Aged; Aged, 80 and over; Albuterol; Anti-Asthmatic Agents; Asthma; Budesonide; Cognition Disorders;

2010